PRESS DIGEST- Financial Times - Feb 20
Feb 20 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Jan 10 Bristol-Myers Squibb Co
* Bristol-Myers Squibb CEO says expects oncology portfolio to be impacted by competition in 2017, particularly in lung cancer
* Bristol-Myers sees potential for pivotal data from 14 trials in 10 tumor types over next 24 months
* Bristol-Myers sees operating expenses remaining at 2016 level of about $9 billion through 2020
* Bristol-Myers CEO says business development remains key component of research and development strategy - JP Morgan Healthcare Conference Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)
NEW YORK, Feb 19 U.S. food company Kraft Heinz Co withdrew its proposal for a $143-billion merger with larger rival Unilever Plc, the companies said on Sunday, raising questions about whether Kraft will turn its focus to another target.
LONDON, Feb 17 John Fallon needs to show he has a plan to navigate Pearson through the sinking sands of its main markets when the world's biggest education company reports full-year results.